---
schema_version: "secwatch.filing_event.v1"
accession: "0000049071-25-000021"
form_type: "8-K"
ticker: "HUM"
cik: "0000049071"
company_name: "HUMANA INC"
filed_at: "2025-04-30T23:59:59+00:00"
generated_at: "2026-05-23T02:55:29.895121+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Humana Q1 GAAP EPS $10.30, Adjusted EPS $11.58; affirms FY adjusted EPS ~$16.25

## Summary
- Q1 GAAP EPS $10.30 vs $6.11 YoY; Adjusted EPS $11.58 vs $7.23 YoY; revenue $32.1B up 8.4%.
- Insurance segment benefit ratio 87.4% in line with ~87.5% expectation; affirms FY 2025 benefit ratio guidance 90.1%-90.5%.
- Revises FY 2025 GAAP EPS guidance to ~$14.68 from ~$15.88; affirms Adjusted EPS guidance ~$16.25.
- Expects individual Medicare Advantage membership decline of ~550k in 2025 due to planned plan exits.
- CenterWell selected as fulfillment pharmacy for NovoCare weight-loss drug; Illinois intends to award Dual Eligible SNP contract.

## SEC filing metadata
- accession: 0000049071-25-000021
- form_type: 8-K
- ticker: HUM
- cik: 0000049071
- company_name: HUMANA INC
- filed_at: 2025-04-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/49071/000004907125000021/0000049071-25-000021-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/49071/000004907125000021/hum-20250430.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000049071-25-000021
- JSON: https://secwatch.observer/filing/0000049071-25-000021.json
- Plain text: https://secwatch.observer/filing/0000049071-25-000021.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.